Joana Maria Taltavull-Aparicio
Overview
Explore the profile of Joana Maria Taltavull-Aparicio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
6
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zamanillo-Campos R, Fiol-deRoque M, Serrano-Ripoll M, Llobera-Canaves J, Llobera J, Taltavull-Aparicio J, et al.
Br J Gen Pract
. 2024 Oct;
PMID: 39362693
Background: Complications arising from uncontrolled type 2 diabetes mellitus (T2DM) pose a significant burden on individuals' wellbeing and healthcare resources. Digital interventions may play a key role in mitigating such...
2.
Rico-Blazquez M, Esteban-Sepulveda S, Sanchez-Ruano R, Aritztegui-Echenique A, Artigues-Barbera E, Brito-Brito P, et al.
Front Public Health
. 2024 Jul;
12:1389641.
PMID: 38952731
Aims: To assess the impact of the COVID-19 pandemic on the health condition of people ≥75 years of age and on their family caregivers in Spain. Design: Multicentric, mixed method...
3.
Zamanillo-Campos R, Fiol-deRoque M, Serrano-Ripoll M, Mira-Martinez S, Llobera-Canaves J, Taltavull-Aparicio J, et al.
Contemp Clin Trials
. 2023 Nov;
136:107399.
PMID: 37995967
Aim: To evaluate the effectiveness of DiabeText, a low-intensity, multifaceted, mobile health (mHealth) intervention to support medication taking and lifestyle change targeted to people with type 2 diabetes (T2D). Design:...
4.
Zamanillo-Campos R, Serrano-Ripoll M, Taltavull-Aparicio J, Gervilla-Garcia E, Ripoll J, Fiol-deRoque M, et al.
Int J Environ Res Public Health
. 2022 Apr;
19(7).
PMID: 35409916
Background: Antidiabetic medication is effective in preventing diabetes-related complications. However, 40% of type 2 diabetic patients do not adhere to their medication regimes adequately. Brief text messages represent a promising...
5.
Zamanillo-Campos R, Serrano-Ripoll M, Taltavull-Aparicio J, Gervilla-Garcia E, Ripoll J, Fiol-deRoque M, et al.
Int J Environ Res Public Health
. 2022 Feb;
19(3).
PMID: 35162921
Background: Type 2 Diabetes Mellitus (T2DM) is a long-term condition affecting around 10% of people worldwide. This study aimed to explore T2DM patients' views on DiabeText, a new text messaging...
6.
Molina-Mula J, Miguelez-Chamorro A, Taltavull-Aparicio J, Miralles-Xamena J, Ortego-Mate M
Healthcare (Basel)
. 2020 Aug;
8(3).
PMID: 32846995
Background: The complex chronic patient is a person with one or several long-term diseases, the clinical management of which are considered difficult and related to cognitive or functional impairment. The...